389 related articles for article (PubMed ID: 28746017)
1. Tumor Evolution, Heterogeneity, and Therapy for Our Patients With Advanced Cancer: How Far Have We Come?
El-Deiry WS; Taylor B; Neal JW
Am Soc Clin Oncol Educ Book; 2017; 37():e8-e15. PubMed ID: 28746017
[TBL] [Abstract][Full Text] [Related]
2. Intra-tumour heterogeneity - going beyond genetics.
Caiado F; Silva-Santos B; Norell H
FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
[TBL] [Abstract][Full Text] [Related]
3. Roles of tumor heterogeneity in the development of drug resistance: A call for precision therapy.
Wu D; Wang DC; Cheng Y; Qian M; Zhang M; Shen Q; Wang X
Semin Cancer Biol; 2017 Feb; 42():13-19. PubMed ID: 27840278
[TBL] [Abstract][Full Text] [Related]
4. Understanding the Cause and Consequence of Tumor Heterogeneity.
Khatib S; Pomyen Y; Dang H; Wang XW
Trends Cancer; 2020 Apr; 6(4):267-271. PubMed ID: 32209440
[TBL] [Abstract][Full Text] [Related]
5. A population genetics perspective on the determinants of intra-tumor heterogeneity.
Hu Z; Sun R; Curtis C
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):109-126. PubMed ID: 28274726
[TBL] [Abstract][Full Text] [Related]
6. Engineering Multidimensional Evolutionary Forces to Combat Cancer.
McCoach CE; Bivona TG
Cancer Discov; 2019 May; 9(5):587-604. PubMed ID: 30992280
[TBL] [Abstract][Full Text] [Related]
7. Novel insights into the disease dynamics of B-cell lymphomas in the Genomics Era.
Chan FC; Lim E; Kridel R; Steidl C
J Pathol; 2018 Apr; 244(5):598-609. PubMed ID: 29359812
[TBL] [Abstract][Full Text] [Related]
8. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
[TBL] [Abstract][Full Text] [Related]
9. Drivers of dynamic intratumor heterogeneity and phenotypic plasticity.
Biswas A; De S
Am J Physiol Cell Physiol; 2021 May; 320(5):C750-C760. PubMed ID: 33657326
[TBL] [Abstract][Full Text] [Related]
10. Addressing intra-tumoral heterogeneity and therapy resistance.
Rybinski B; Yun K
Oncotarget; 2016 Nov; 7(44):72322-72342. PubMed ID: 27608848
[TBL] [Abstract][Full Text] [Related]
11. The challenges of tumor genetic diversity.
Mroz EA; Rocco JW
Cancer; 2017 May; 123(6):917-927. PubMed ID: 27861749
[TBL] [Abstract][Full Text] [Related]
12. Changing mutational and adaptive landscapes and the genesis of cancer.
Liggett LA; DeGregori J
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):84-94. PubMed ID: 28167050
[TBL] [Abstract][Full Text] [Related]
13. Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance.
Zhang A; Miao K; Sun H; Deng CX
Int J Biol Sci; 2022; 18(7):3019-3033. PubMed ID: 35541919
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathology in real time.
Ryška A
Cancer Metastasis Rev; 2016 Mar; 35(1):129-40. PubMed ID: 26931654
[TBL] [Abstract][Full Text] [Related]
15. Impact of cancer metabolism on therapy resistance - Clinical implications.
Gonçalves AC; Richiardone E; Jorge J; Polónia B; Xavier CPR; Salaroglio IC; Riganti C; Vasconcelos MH; Corbet C; Sarmento-Ribeiro AB
Drug Resist Updat; 2021 Dec; 59():100797. PubMed ID: 34955385
[TBL] [Abstract][Full Text] [Related]
16. Targeted therapy in cancer.
Tsimberidou AM
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1113-32. PubMed ID: 26391154
[TBL] [Abstract][Full Text] [Related]
17. Tumor heterogeneity-driven individualized therapy.
Baltagiannis EG; Ziogas DE; Cho WC; Mitsis M; Roukos DH
Future Oncol; 2021 Jan; 17(3):235-240. PubMed ID: 33305621
[No Abstract] [Full Text] [Related]
18. Tumor microenvironment and cancer therapy resistance.
Sun Y
Cancer Lett; 2016 Sep; 380(1):205-15. PubMed ID: 26272180
[TBL] [Abstract][Full Text] [Related]
19. Clonal evolution and tumor-initiating cells: New dimensions in cancer patient treatment.
Apostoli AJ; Ailles L
Crit Rev Clin Lab Sci; 2016; 53(1):40-51. PubMed ID: 26397062
[TBL] [Abstract][Full Text] [Related]
20. Evolutionary scalpels for dissecting tumor ecosystems.
Rosenbloom DIS; Camara PG; Chu T; Rabadan R
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):69-83. PubMed ID: 27923679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
